>>New Products>>GMax™ LiposomeRNA Transfection Reagent

GMax™ LiposomeRNA Transfection Reagent

Catalog No.GK20007

GMax™ 리포좀 RNA 전달 시약은 다양한 세포 유형에서 가장 높은 전달 효율을 얻을 수 있으며, siRNA 매개 유전자 억제 실험에 적합합니다.

Products are for research use only. Not for human use. We do not sell to patients.

GMax™ LiposomeRNA Transfection Reagent Chemical Structure

Size 가격 재고 수량
0.5mL
US$350.00
재고 있음
0.25mL
US$190.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Components Product Documents Related Video Related Products

GMax™ LiposomeRNA Transfection Reagent can obtain the highest transfection efficiency in a variety of cell types, and is suitable for siRNA-mediated gene suppression experiments. GMax™ LiposomeRNA is a unique RNAi-specific cationic liposome transfection reagent, suitable for delivering siRNA and miRNA to all cell types.

• Ultra-high transfection efficiency, and low RNAi concentration required, better gene suppression effect, few non-specific effects.
• Low cytotoxicity, easy to optimize, showing low cytotoxicity across the 10-fold transfection reagent concentration range.
• Excellent transfection efficiency for miRNA antagonists and mimics.
• It can be used in a variety of cell types and is the most versatile method suitable for various gene suppression experiments.
• Simple and fast experimental protocol to obtain stable and reproducible results.

리뷰

Review for GMax™ LiposomeRNA Transfection Reagent

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GMax™ LiposomeRNA Transfection Reagent

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.